Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Sep;46(9):3042-4.
doi: 10.1128/AAC.46.9.3042-3044.2002.

Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis

Teresa H Bacon  1 , Ron J Boon, Margaret Schultz, Cheryl Hodges-Savola
Affiliations

Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis

Teresa H Bacon et al. Antimicrob Agents Chemother. 2002 Sep.

Abstract

In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals with an episode of recurrent herpes labialis not treated with topical antiviral agents. Two isolates had borderline resistance to acyclovir (0.2%), and all were susceptible to penciclovir.

PubMed Disclaimer

References

    1. Boon, R. J., T. H. Bacon, H. L. Robey, T. J. Coleman, A. Connolly, P. Crosson, and S. L. Sacks. 2000. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based study. J. Antimicrob. Chemother. 46:324-325. (Erratum, 46: 1051.) - PubMed
    1. Christophers, J., J. Clayton, J. Craske, R. Ward, P. Collins, M. Trowbridge, and G. Darby. 1998. Survey of resistance of herpes simplex virus to acyclovir in Northwest England. Antimicrob. Agents Chemother. 42:868-872. - PMC - PubMed
    1. Collins, P., and M. N. Ellis. 1993. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol. 1993(Suppl. 1):58-66. - PubMed
    1. Sacks, S. L., R. A. Thisted, T. M. Jones, R. A. Barbarash, D. J. Mikolich, G. E. Ruoff, J. L. Jorizzo, L. B. Gunnill, D. H. Katz, M. H. Khalil, P. R. Morrow, G. J. Yakatan, L. E. Pope, and J. E. Berg for the Docosanol 10% Cream Study Group. 2001. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J. Am. Acad. Dermatol. 45:222-230. - PubMed
    1. Safrin, S., T. Elbeik, L. Phan, D. Robinson, J. Rush, A. Elbaggari, and J. Mills. 1994. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 38:1246-1250. - PMC - PubMed

MeSH terms